|1.||Jarus-Dziedzic, K: 2 articles (04/2000 - 03/2000)|
|2.||Cervos-Navarro, J: 2 articles (04/2000 - 03/2000)|
|3.||Czernicki, Z: 2 articles (04/2000 - 03/2000)|
|4.||Jurkiewicz, J: 2 articles (04/2000 - 03/2000)|
|5.||Kuridze, N: 2 articles (04/2000 - 03/2000)|
|6.||Gonul, Engin: 1 article (01/2011)|
|7.||Izci, Yusuf: 1 article (01/2011)|
|8.||Tehli, Ozkan: 1 article (01/2011)|
|9.||Erdogan, Ersin: 1 article (01/2011)|
|10.||Solmaz, Ilker: 1 article (01/2011)|
04/01/2000 - "The obtained results revealed a strong antivasoconstrictive effect of Dotarizine on cerebral vessels reactivity during hyperventilation. "
01/01/1995 - "The most conspicuous data were obtained in experiments conducted in hyperventilated animals where dotarizine abolished the vasoconstrictive effect of hyperventilation. "
03/01/2000 - "In this study the efficacy of Dotarizine chronic oral administration on cerebrovascular reactivity during hyperventilation was examined with respect to its duration of action. "
04/01/2000 - "From the obtained results it can be concluded that chronic oral administration of a novel compound (Dotarizine) diminishes the vasoconstrictive effect of hyperventilation on cerebral vessels in rabbits. "
01/01/1997 - "The results revealed that oral administration of Dotarizine diminished the vasoconstrictive effect of hyperventilation and this was more pronounced in MCA than in BA. "
01/01/1998 - "The effect of Dotarizine--(Ca2+ channel blocker)--on vascular reactivity and ultrastructure of cerebral capillaries in animals subjected to anoxia."
01/01/1999 - "In the study presented the effect of Dotarizine on blood flow velocity in cerebral arteries - in middle cerebral artery (MCA), and basilar artery (BA)- was investigated and compared utilising transcranial Doppler sonography during normoventilation, 15 min hyperventilation with subsequent 3 min anoxia in anaesthetized rabbits. "
01/01/1999 - "The results revealed that decrease of flow velocity caused by hyperventilation and increase during anoxia were less pronounced in the Dotarizine treated group than in control group of animals. "
01/01/1997 - "The effect of Dotarizine (Ca2+ channel blocker) on cerebral vessel reactivity in animals subjected to hyperventilation and anoxia."
|4.||Vertigo (Positional Vertigo)
01/01/1998 - "This study confirms the value of dotarizine in the treatment of peripheral vertigo."
01/01/1998 - "Results showed that dotarizine was significantly active against the vertigo attacks and its associated symptoms (mainly neurovegetative). "
01/01/1998 - "The global superiority of dotarizine was confirmed by statistically significant differences between treatments in the improvement of the severity of vertigo, hearing loss in audiometries, global relief of symptoms, disability produced by crises and global assessment by the investigators themselves. "
01/01/1998 - "One hundred and ten adult patients suffering from peripheral vertigo were treated in a multifactorial double-blind randomized clinical trial with dotarizine (50 mg b.i.d.) or cinnarizine (75 mg b.i.d.). "
01/01/1998 - "[Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)]."
|5.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/01/2011 - "The aim of this study was to assess and to compare the ability of intrathecal dotarizine and nimodipine to prevent and treat vasospasm in a rabbit model of subarachnoid hemorrhage. "
01/01/2011 - "Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits."
|3.||glucuronyl glucosamine glycan sulfate (Vessel)